Peter Annas - Concepedia

Author

Peter Annas

Uppsala University ORCID

Also Known As

Annas, Peter, BWJH Penninx, Brenda W J H Penninx, Brenda W. J. H. Penninx, P Annas, P. Annas, PETER ANNAS, Peter Annas

Publications

3.8K

Citations

H-Index

Concepts

All Affiliations

Uppsala University AstraZeneca (Sweden)Lundbeck (Denmark)King's College London Universitat de Barcelona

About

Peter Annas is an author at Uppsala University specializing in social sciences, neuroscience, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Social Sciences	10	10	1.1K
2	Medicine	9	9	1.3K
3	Health Sciences	5	5	706
4	Education	1	1	11
5	Engineering	1	1	14

Peter Annas

Publications

3.5K

Citations

H-Index

Page 1

	Year	Citations
Gender and age differences in the prevalence of specific fears and phobias Mats Fredrikson, Peter Annas, Håkan Fischer, Behaviour Research and Therapy Psychological Co-morbiditiesBehavioral SciencesGender IdentityGender StudiesPsychology	1996	544
Lithium trial in Alzheimer's disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study. Harald Hampel, Michael Ewers, Katharina Bürger, PubMed NeuropsychiatryNeurochemical BiomarkersTau ProteinGeriatric NeurologyAlzheimer's Disease	2009	306
Lithium Trial in Alzheimer's Disease Harald Hampel, Michael Ewers, Katharina Bürger, The Journal of Clinical Psychiatry NeuropsychiatryNeurochemical BiomarkersTau ProteinGeriatric NeurologyAlzheimer's Disease	2009	283
Functional neuroanatomy of visually elicited simple phobic fear: Additional data and theoretical analysis M Fredrikson, Gustav Wik, Peter Annas, Psychophysiology	1995	196
Longitudinal stability of CSF biomarkers in Alzheimer's disease Kaj Blennow, Henrik Zetterberg, Lennart Minthon, Neuroscience Letters Alzheimer's DiseaseCsf BiomarkersDementiaBiomarkersNeurochemical Biomarkers	2007	189
A Twin Study of the Genetics of Fear Conditioning John M. Hettema, Peter Annas, Michael C. Neale, Archives of General Psychiatry	2003	173
Increase of BDNF Serum Concentration in Lithium Treated Patients with Early Alzheimer's Disease Thomas Leyhe, Gerhard W. Eschweiler, Elke Stransky, Journal of Alzheimer s Disease Neurodegenerative DiseasesNeuropsychologyAlzheimer's DiseaseBdnf Serum LevelsPsychiatry	2009	155
Human fear conditioning is related to dopaminergic and serotonergic biological markers. Håkan Garpenstrand, Peter Annas, Jonas Ekblom, Behavioral Neuroscience NeuropsychologyAffective NeurosciencePsychopharmacologySocial SciencesPsychology	2001	154
Microglial Markers are Elevated in the Prodromal Phase of Alzheimer's Disease and Vascular Dementia Bob Olsson, Joakim Hertze, Ronald Lautner, Journal of Alzheimer s Disease	2012	125
Human fear conditioning is related to dopaminergic and serotonergic biological markers. Håkan Garpenstrand, Peter Annas, Jonas Ekblom, Behavioral Neuroscience Neurobiological MechanismNeuropsychologyBehavioral NeuroscienceAffective NeuroscienceBiological Markers	2001	120

Page 1